• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Model Number H7493926028300
Device Problem Occlusion Within Device (1423)
Patient Problems Chest Pain (1776); Thrombosis (2100)
Event Date 03/31/2018
Event Type  Injury  
Manufacturer Narrative
Device is combination product.Device evaluated by mfr.: it is indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.(b)(4).
 
Event Description
Same case as mdr id: 2134265-2018-03555.It was reported that chest pain and acute stent thrombosis occurred.In (b)(6) 2018, the patient presented with st-elevation myocardial infarction.Vascular access was obtained via the right femoral artery utilizing retrograde approach.The 100% stenosed, 12 mm in length target lesion was located in the proximal left anterior descending (lad) artery.A 6fr sheath was inserted and a guide wire was advanced and crossed the lesion.Following predilatation with a non-bsc balloon, a 3.00 x 28 mm synergy ii drug-eluting stent was deployed at 12 atmospheres (atm) for 16 seconds.A 3.25 x 15 mm nc emerge balloon catheter was advanced for further dilatation at 12 atm for 17 seconds.Following dilatation, the devices were removed and hemostasis was successfully obtained.Post procedure, the patient was given effient and was resting comfortably with no acute distress noted.Following completion of the percutaneous coronary intervention (pci), the patient was transferred to the intensive care unit (icu) where they complained of chest pain.Repeat electrocardiogram (ecg) was performed which showed the exact same pattern as prior to the pci and a repeat angiogram confirmed acute stent thrombosis at the proximal segment of the stent.A 3.5 mm x 15 mm nc emerge balloon catheter was advanced and inflated the entire stent at 10 atm for 11 seconds, 12 atm for 6 seconds, 12 atm for 8 seconds, and 12 atm for 12 seconds.The stent appeared to have a good apposition and the vessel re-opened with timi-3 flow but there was haziness at the proximal stent segment.The physician deployed a 3.5 x 18 mm non-bsc stent at 14 atm for 14 seconds to cover the proximal segment of the synergy stent.The initial 100% stenosis was reduced resulting in 0% residual with normal timi-3 flow.No further patient complications were reported and the patient's status was good.The patient was kept on aggrastat infusion for 18 hours and was discharged on dual-antiplatelet with aspirin and effient.The patient was enrolled in cardiac rehab upon discharge.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM
Type of Device
BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key7459087
MDR Text Key106459712
Report Number2134265-2018-03410
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08714729840299
UDI-Public08714729840299
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 04/02/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/02/2019
Device Model NumberH7493926028300
Device Catalogue Number39260-2830
Device Lot Number21571288
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/02/2018
Initial Date FDA Received04/25/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/02/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age62 YR
-
-